Clinical significance of drug cessation on medication-related

Kezia-Rachellea MUSTAKIM; Mi-Young EO; Ju-Young LEE; Mi-Hyun SEO; Soung-Min KIM.
Journal of the Korean Association of Oral and Maxillofacial Surgeons ; : 75-85, 2023.
Artículo en Inglés | WPRIM | ID: wpr-977016

Documentos relacionados

  1. Clinical significance of drug cessation on medication-related osteonecrosis of the jaw in patients with osteoporosis.
  2. The role of M1 and M2 macrophage polarization in progression of medication-related osteonecrosis of the jaw.
  3. Interventions for managing medication-related osteonecrosis of the jaw.
  4. Bone turnover markers can predict healing time in medication-related osteonecrosis of the jaw.
  5. Medication-related osteonecrosis of the jaw: Osteoclast profile in comparison with osteoradionecrosis of the jaw and osteomyelitis of the jaw.
  6. A microparticle blood analogue suspension matching blood rheology.
  7. EFFICACY AND SAFETY OF BISPHOSPHONATE THERAPY IN MCCUNE-ALBRIGHT SYNDROME-RELATED POLYOSTOTIC FIBROUS DYSPLASIA: A SINGLE-CENTER EXPERIENCE.
  8. Impact of different syringe pumps on red cells during paediatric simulated transfusion.
  9. Stage-specific therapeutic strategies of medication-related osteonecrosis of the jaws: a systematic review and meta-analysis of the drug suspension protocol.
  10. Can medication-related osteonecrosis of the jaw be attributed to specific microorganisms through oral microbiota analyses? A preliminary study.